This topic contains a solution. Click here to go to the answer

Author Question: Kwashiorkor describes a condition of severe emaciation from energy deficiency with chronic wasting ... (Read 14 times)

Shelles

  • Hero Member
  • *****
  • Posts: 582
Kwashiorkor describes a condition of severe emaciation from energy deficiency with chronic wasting of fat, muscle, and other tissues, also known as starvation.
 a. True
  b. False
  Indicate whether the statement is true or false

Question 2

In 2000, the decision was made to merge NHANES and CSFII into a single, more cost-effective survey.
 a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ririgirl15

  • Sr. Member
  • ****
  • Posts: 385
Answer to Question 1

False

Answer to Question 2

True




Shelles

  • Member
  • Posts: 582
Reply 2 on: Aug 21, 2018
Wow, this really help


frankwu0507

  • Member
  • Posts: 322
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library